NORGES BANK - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q4 2022$8,252,888
+7.3%
1,080,2210.0%0.00%0.0%
Q3 2022$7,691,174
-15.5%
1,080,221
-4.0%
0.00%0.0%
Q2 2022$9,106,711
-38.4%
1,125,675
+5.7%
0.00%
-33.3%
Q1 2022$14,788,710
-49.3%
1,065,469
+2.6%
0.00%
-50.0%
Q4 2021$29,144,000
-11.6%
1,038,623
+7.1%
0.01%
-14.3%
Q3 2021$32,960,000
-11.8%
969,709
+6.0%
0.01%
-12.5%
Q2 2021$37,382,000
+38.6%
914,879
+36.6%
0.01%
+33.3%
Q1 2021$26,968,000
-44.9%
669,842
-19.1%
0.01%
-45.5%
Q4 2020$48,953,000
+8.7%
827,880
-10.6%
0.01%
-8.3%
Q3 2020$45,020,000
+1304.2%
925,761
+1297.0%
0.01%
+1100.0%
Q2 2020$3,206,000
+74.1%
66,2690.0%0.00%0.0%
Q1 2020$1,841,000
+278.0%
66,269
+307.3%
0.00%
Q4 2019$487,000
-65.0%
16,269
-63.8%
0.00%
Q3 2019$1,391,000
-36.0%
45,0000.0%0.00%
-100.0%
Q2 2019$2,174,00045,0000.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2022
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$20,334,21213.72%
BERYLSON CAPITAL PARTNERS, LLC 228,000$1,529,8804.32%
Eagle Health Investments LP 1,214,860$8,151,7111.52%
Matrix Capital Management Company, LP 11,572,590$77,652,0790.90%
Triatomic Management LP 121,166$813,0240.83%
VIKING GLOBAL INVESTORS LP 29,993,708$201,257,7810.82%
Aristotle Atlantic Partners, LLC 3,104,961$20,834,2880.78%
Pier Capital, LLC 737,589$4,949,2220.71%
ARK Investment Management 10,453,752$70,144,6750.46%
Nikko Asset Management Americas, Inc. 6,384,047$42,773,1150.45%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders